Tag archive for ‘Anat Cohen-Dayag’

John Hopkins University and Compugen team on immune checkpoints

– The collaboration will focus on immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. –   Compugen Ltd. (Nasdaq: CGEN; TASE: CGEN) today announced the More...

Ilan Shavit On Monday, August 5th, 2013

Compugen drug discovery company signs $500 million agreement with Bayer

– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan Shavit More...

Wordpress site Developed by Fixing WordPress Problems